-+ 0.00%
-+ 0.00%
-+ 0.00%

vTv Therapeutics Q4 2024 GAAP EPS $(0.55) Beats $(0.87) Estimate

Benzinga·03/20/2025 21:37:40
Listen to the news
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.87) by 36.78 percent. This is a 67.07 percent increase over losses of $(1.67) per share from the same period last year.